Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Trial of celecoxib in amyotrophic lateral sclerosis.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, Drachman DB.

Ann Neurol. 2006 Jul;60(1):22-31.

PMID:
16802291
2.

A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis.

Pascuzzi RM, Shefner J, Chappell AS, Bjerke JS, Tamura R, Chaudhry V, Clawson L, Haas L, Rothstein JD.

Amyotroph Lateral Scler. 2010 May 3;11(3):266-71. doi: 10.3109/17482960903307805.

PMID:
19961264
3.

A clinical trial of creatine in ALS.

Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, Pestronk A, Caress J, Donofrio P, Sorenson E, Bradley W, Lomen-Hoerth C, Pioro E, Rezania K, Ross M, Pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, Smith-Palmer T, MacDonald D, Burke D; NEALS Consortium.

Neurology. 2004 Nov 9;63(9):1656-61.

PMID:
15534251
4.

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr, Johnson H, Qureshi M, Jacobs M, Rothstein JD, Appel SH, Pascuzzi RM, Heiman-Patterson TD, Donofrio PD, David WS, Russell JA, Tandan R, Pioro EP, Felice KJ, Rosenfeld J, Mandler RN, Sachs GM, Bradley WG, Raynor EM, Baquis GD, Belsh JM, Novella S, Goldstein J, Hulihan J; Northeast ALS Consortium.

Neurology. 2003 Aug 26;61(4):456-64.

PMID:
12939417
5.

Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.

Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M.

Ann Rheum Dis. 2008 Mar;67(3):323-9. Epub 2007 Jul 6.

6.

Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.

Daniels S, Robbins J, West CR, Nemeth MA.

Clin Ther. 2009 Jun;31(6):1192-208. doi: 10.1016/j.clinthera.2009.06.003.

PMID:
19695387
7.

Revised statistical motor unit number estimation in the Celecoxib/ALS trial.

Shefner JM, Cudkowicz ME, Zhang H, Schoenfeld D, Jillapalli D; Northeast ALS Consortium.

Muscle Nerve. 2007 Feb;35(2):228-34.

PMID:
17058270
8.

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group.

Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, Hoagland RJ, Parry GJ, Ross MA, Stromatt SC.

Ann Neurol. 1996 Feb;39(2):256-60.

PMID:
8967757
9.

A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.

Reuben SS, Buvenandran A, Katz B, Kroin JS.

Anesth Analg. 2008 Apr;106(4):1258-64, table of contents. doi: 10.1213/ane.0b013e318165e208. Retraction in: Shafer SL. Anesth Analg. 2009 Apr;108(4):1350.

PMID:
18349203
10.
11.

Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.

White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, Weiner E, Verburg KM.

Am J Cardiol. 2007 Jan 1;99(1):91-8. Epub 2006 Nov 10.

PMID:
17196469
12.

Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.

Barkhuizen A, Steinfeld S, Robbins J, West C, Coombs J, Zwillich S.

J Rheumatol. 2006 Sep;33(9):1805-12.

PMID:
16960941
14.

A randomized sequential trial of creatine in amyotrophic lateral sclerosis.

Groeneveld GJ, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, Wokke JH, Franssen H, van den Berg LH.

Ann Neurol. 2003 Apr;53(4):437-45.

PMID:
12666111
15.

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.

ADAPT Research Group, Lyketsos CG, Breitner JC, Green RC, Martin BK, Meinert C, Piantadosi S, Sabbagh M.

Neurology. 2007 May 22;68(21):1800-8. Epub 2007 Apr 25.

PMID:
17460158
16.

Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis.

Jajić Z, Malaise M, Nekam K, Koó E, Dankó K, Kovacs M, Scarpignato C.

Clin Exp Rheumatol. 2005 Nov-Dec;23(6):809-18.

PMID:
16396699
17.

Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.

Meininger V, Asselain B, Guillet P, Leigh PN, Ludolph A, Lacomblez L, Robberecht W; Pentoxifylline European Group.

Neurology. 2006 Jan 10;66(1):88-92.

PMID:
16401852
18.

Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.

Bingham CO 3rd, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM.

Rheumatology (Oxford). 2007 Mar;46(3):496-507. Epub 2006 Aug 27.

19.

The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.

Soni P, Shell B, Cawkwell G, Li C, Ma H.

Curr Med Res Opin. 2009 Aug;25(8):1841-51. doi: 10.1185/03007990903018279.

PMID:
19530981
20.

A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis.

de Carvalho M, Pinto S, Costa J, Evangelista T, Ohana B, Pinto A.

Amyotroph Lateral Scler. 2010 Oct;11(5):456-60. doi: 10.3109/17482968.2010.498521.

PMID:
20565333
Items per page

Supplemental Content

Write to the Help Desk